YOLFTbeta
CA

Cantargia AB

CANTA · ST · Healthcare / Biotechnology

1.39SEK-0.01 (-0.93%)

Price History

Full chart

Market Stats

Previous Close1.40
Open1.41
Day Range1.39 – 1.44
52-Week Range1.39 – 6.59
Volume842.70K
Market Cap397.26M
P/E (TTM)2.10
Forward P/E2.74
EPS0.67
Dividend Yield0.00%
Beta1.59
50-Day Avg1.73
200-Day Avg3.23

About

Cantargia AB (publ), a biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases. The company is developing CAN04 (nadunolimab), an monoclonal antibody that can bind IL1RAP, which is in phase II clinical trial for the treatment of pancreatic cancer, non-small cell lung cancer, and triple-negative breast cancer; and CAN10, an antibody against IL1RAP, which is in phase 1 clinical trial for the treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis. It also develops CANxx, an IL1RAP-based antibody platform. The company has collaboration agreements with Otsuka Pharmaceutical Co., Ltd for the clinical IL1RAP targeting antibody CAN10 as well as the preclinical antibody 3G5; and BioWa Inc., granted a nonexclusive license to use the technology platform POTELLIGENT® for the manufacture of the drug candidate nadunolimab. Cantargia AB (publ) was incorporated in 2009 and is based in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Hilde Hermansen Steineger M.Sc., MSc, Ph.D.
  • Employees22
  • HeadquartersIdeon Gateway, Lund, Sweden, 223 63, Sweden
  • Websitehttps://cantargia.com

Leadership

  • Dr. Hilde Hermansen Steineger M.Sc., MSc, Ph.D.Chief Executive Officer · b. 1966
  • Mr. Thoas Fioretos M.D., Ph.D.Founder & Scientific Advisor · b. 1962
  • Mr. Marcus JäråsFounder & Scientific Advisor
  • Mr. Kjell SjöströmFounder
  • Mr. Patrik RenbladChief Financial Officer · b. 1970
  • Dr. David LibergChief Scientific Officer · b. 1969
  • Ms. Nina ValkamaExecutive Assistant of Administration & Finance
  • Mr. Antonius BerkienChief Business Officer · b. 1968
  • Johanna ChristensenFinancial Controller

Financials

Income Statement

Currency: SEK2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-----000000000316.70M
Cost of Revenue-1.83K5.77M3.50M7.04M35.49M6.92M-12.00K3.25M3.45M3.69M3.45M3.44M3.27M
Gross Profit--1.83K-5.77M-3.50M-7.04M-35.49M-6.92M--12.00K-3.25M-3.45M-3.69M-3.45M-3.44M313.43M
Gross Margin--------------98.97%
Operating Expense-3.52M2.21M4.62M9.97M9.25M53.09M-111.58M170.70M366.82M377.86M286.57M165.15M159.04M
Operating Income-3.41M-3.52M-7.98M-8.12M-17.02M-44.75M-60.01M-93.31M-111.59M-173.94M-370.27M-381.55M-290.02M-168.58M154.39M
Operating Margin--------------48.75%
EBITDA-3.39M-3.46M-7.95M-8.37M-17.00M-91.00K-453.00K1.61M-110.80M-169.84M-363.06M-368.12M-284.31M-165.05M154.37M
EBITDA Margin--------------48.74%
Net Income-3.39M-3.46M-7.95M-8.37M-17.19M-44.68M-60.25M-91.16M-110.81M-173.09M-366.50M-371.81M-280.03M-161.65M146.97M
Net Income Margin--------------46.41%
R&D1.88M1.83M5.77M-7.04M35.49M52.42M76.95M97.48M158.40M352.71M364.69M272.88M153.78M132.75M
R&D as % of Total Revenue--------------41.92%
Interest Expense3.50K51.83K31.72K252.57K67.00K2.00K2.00K1.00K480.00K1.00K3.00K4.00K6.37M2.10M13.58M
Interest Expense % of Total Revenue--------------4.29%

Balance Sheet

Currency: SEK2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.40M3.77M3.99M20.13M31.38M47.51M274.45M171.44M166.06M925.51M600.24M474.80M223.71M170.43M296.66M
Total Liabilities861.27K697.32K858.07K16.03M3.33M10.38M28.33M16.40M23.78M33.58M67.50M85.11M54.97M54.12M30.78M
Total Equity1.54M3.08M3.13M4.10M28.05M37.13M246.12M155.04M142.27M891.93M532.75M389.68M168.74M116.30M265.88M
Cash1.94M2.65M1.50M16.66M9.64M25.90M149.78M76.53M39.87M693.35M247.32M189.57M139.75M33.04M281.82M
Net Debt-1.94M-2.65M-1.50M-16.66M-9.64M-25.90M-149.78M-76.53M-39.87M-693.35M-247.32M-189.57M-139.75M-33.04M-281.82M

Cash Flow

Currency: SEK2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.92M-3.78M-8.26M6.90M-30.28M-39.53M-41.10M-104.69M-111.25M-156.39M-346.44M-358.92M-286.66M-162.75M150.13M
Investing Cash Flow-255.28K-504.69K-893.66K-1.07M-3.02M-3.90M-111.36M29.68M-23.62M-109.00M-102.43M67.88M182.09M55.00M-472.00K
Financing Cash Flow3.30M5.00M8.00M9.34M41.15M53.75M276.34M85.00K98.04M918.51M3.00K223.93M54.68M-1.07M103.86M
Capital Expenditure000676.30K1.83M2.81M6.88M6.88M6.88M9.00M383.00K7.09M00472.00K
Free Cash Flow-2.92M-3.78M-8.26M6.22M-32.11M-42.34M-41.10M-104.69M-118.13M-165.39M-346.83M-366.00M-286.66M-162.75M149.66M
FCF to OCF100.00%100.00%100.00%90.20%106.06%107.11%100.00%100.00%106.18%105.76%100.11%101.98%100.00%100.00%99.69%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Mar 1, 2016May 16, 2016Aug 24, 2016Nov 21, 2016May 15, 2017Aug 23, 2017Nov 8, 2017Feb 28, 2018May 15, 2018Aug 21, 2018Nov 15, 2018Feb 27, 2019May 27, 2019Aug 22, 2019Nov 15, 2019Feb 27, 2020May 27, 2020Aug 20, 2020Nov 12, 2020Feb 25, 2021May 26, 2021Aug 19, 2021Nov 11, 2021Feb 24, 2022May 23, 2022Aug 30, 2022Nov 10, 2022Feb 23, 2023May 23, 2023Aug 22, 2023Nov 10, 2023Feb 22, 2024May 21, 2024Aug 27, 2024Nov 15, 2024Feb 21, 2025May 13, 2025Aug 21, 2025Nov 19, 2025Feb 20, 2026May 19, 2026Aug 19, 2026Nov 25, 2026
EPS Estimate------------------0.30-0.42-0.41--0.56-0.50--0.72-0.87-0.87----0.54-0.47-0.48-0.38-0.43-------0.17-0.19-0.18-0.17-0.16
EPS Actual-0.42-0.32-0.18-0.29-0.47-0.40-0.56-0.44-0.39-0.28-0.33-0.17-0.35-0.27-0.35-0.30-0.29-0.30-0.41-0.41-0.34-0.43-0.50-0.72-0.86-1.04-1.04-1.17-0.77-0.49-0.54-0.45-0.34-0.46-0.40-0.20-0.24-0.23-0.21-0.19-0.161.07-0.13-0.13-0.13-
Surprise-----------------0.93%1.29%0.17%-23.21%0.12%--19.07%-19.11%-19.52%----0.48%4.26%29.17%-21.05%6.98%------729.41%31.58%27.78%23.53%-
Timing---After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap397.26M
Enterprise Value202.37M
Trailing P/E2.10
Forward P/E2.74
Price / Sales1.25
Price / Book1.61
EPS0.67
Book Value1.06
Revenue (TTM)317.30M
Gross Profit (TTM)317.30M
EBITDA168.57M
Profit Margin52.75%
Operating Margin-37510.53%
Return on Equity113.48%
Return on Assets51.92%
Shares Outstanding281.94M
Shares Float236.26M
Beta1.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 22, 20221174:977
  • Nov 28, 201748:47
  • Jan 17, 201755:53